• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,142
109
76
71
69

COUNTRY

70
22
16
10
9

CATEGORIES

  • 575
  • 121
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,047
1,237
1,991
3,002

PUBLISHED

29
208
647
3,002

PRODUCT TYPE

2,429
494
69
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Refractory Multiple Myeloma - Pipeline Review, H1 2013 Refractory Multiple Myeloma - Pipeline Review, H1 2013 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Review, H1 2013

Refractory Multiple Myeloma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Refractory Multiple Myeloma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Liver Cancer - Pipeline Review, H1 2013 Liver Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H1 2013

Liver Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Liver Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2013 B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2013

B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013

Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013', provides an overview...

February 2013
FROM
Anaplastic Astrocytoma - Pipeline Review, H1 2013 Anaplastic Astrocytoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Anaplastic Astrocytoma - Pipeline Review, H1 2013

Anaplastic Astrocytoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Anaplastic Astrocytoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Bladder Cancer - Pipeline Review, H1 2013 Bladder Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2013

Bladder Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bladder Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Lung Adenocarcinoma - Pipeline Review, H1 2013 Lung Adenocarcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Lung Adenocarcinoma - Pipeline Review, H1 2013

Lung Adenocarcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Lung Adenocarcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Pediatric Cancer - Pipeline Review, H1 2013 Pediatric Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Pediatric Cancer - Pipeline Review, H1 2013

Pediatric Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pediatric Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013 Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013

Peripheral T-Cell Lymphomas (PTCL) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013', provides an overview of the indication’s...

February 2013
FROM
Medullary Thyroid Cancer - Pipeline Review, H1 2013 Medullary Thyroid Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Medullary Thyroid Cancer - Pipeline Review, H1 2013

Global Markets Direct's, 'Medullary Thyroid Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development...

February 2013
FROM
Bone Metastasis - Pipeline Review, H1 2013 Bone Metastasis - Pipeline Review, H1 2013 - Product Thumbnail Image

Bone Metastasis - Pipeline Review, H1 2013

Bone Metastasis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bone Metastasis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Mantle Cell Lymphoma - Pipeline Review, H1 2013 Mantle Cell Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Review, H1 2013

Mantle Cell Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Mantle Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Neuroblastoma - Pipeline Review, H1 2013 Neuroblastoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H1 2013

Neuroblastoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuroblastoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2013 Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2013

Diffuse Large B-Cell Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2013 Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2013 - Product Thumbnail Image

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2013

Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2013', provides...

February 2013
FROM
Metastatic Prostate Cancer - Pipeline Review, H1 2013 Metastatic Prostate Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Review, H1 2013

Metastatic Prostate Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Prostate Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Brain Cancer - Pipeline Review, H1 2013 Brain Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Brain Cancer - Pipeline Review, H1 2013

Brain Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Brain Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Follicular Lymphoma - Pipeline Review, H1 2013 Follicular Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Review, H1 2013

Follicular Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Brain Metastasis - Pipeline Review, H1 2013 Brain Metastasis - Pipeline Review, H1 2013 - Product Thumbnail Image

Brain Metastasis - Pipeline Review, H1 2013

Brain Metastasis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Brain Metastasis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Hepatic (Liver) Tumor - Pipeline Review, H1 2013 Hepatic (Liver) Tumor - Pipeline Review, H1 2013 - Product Thumbnail Image

Hepatic (Liver) Tumor - Pipeline Review, H1 2013

Hepatic (Liver) Tumor – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatic (Liver) Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Loading Indicator

Our Clients

Our clients' logos